Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Gut
|
April 1, 2022
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
Chao Zhang, Jiesheng Li, Yongqian Cheng, et al.
Signal Transduction and Targeted Therapy
|
August 29, 2020
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Fanping Meng, Ruonan Xu, Siyu Wang, et al.
Hepatology Communications
|
December 22, 2021
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC
Anthony Tanoto Tan, Fanping Meng, Jiehua Jin, et al.
Cancer Medicine
|
June 3, 2024
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak
Shaohua Zhang, Lili Tang, Chunmei Bao, et al.
Hepatology International
|
April 15, 2026
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection
Xiao-Yu Li, Peng Zhang, Mengmeng Zhu, et al.
Hepatology International
|
December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
Fanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
Signal Transduction and Targeted Therapy
|
July 28, 2025
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
Lei Shi, Ziying Zhang, Song Mei, et al.
Cellular & Molecular Immunology
|
February 27, 2021
Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
Penghui Yang, Yingze Zhao, Jie Li, et al.
Medcomm
|
July 17, 2024
Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study
Xiaoyan Li, Shanghao Liu, Ying Guo, et al.
Signal Transduction and Targeted Therapy
|
February 11, 2021
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Lei Shi, Hai Huang, Xuechun Lu, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Gut
|
April 1, 2022
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
Chao Zhang, Jiesheng Li, Yongqian Cheng, et al.
Signal Transduction and Targeted Therapy
|
August 29, 2020
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Fanping Meng, Ruonan Xu, Siyu Wang, et al.
Hepatology Communications
|
December 22, 2021
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC
Anthony Tanoto Tan, Fanping Meng, Jiehua Jin, et al.
Cancer Medicine
|
June 3, 2024
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak
Shaohua Zhang, Lili Tang, Chunmei Bao, et al.
Hepatology International
|
April 15, 2026
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection
Xiao-Yu Li, Peng Zhang, Mengmeng Zhu, et al.
Hepatology International
|
December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
Fanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
Signal Transduction and Targeted Therapy
|
July 28, 2025
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
Lei Shi, Ziying Zhang, Song Mei, et al.
Cellular & Molecular Immunology
|
February 27, 2021
Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
Penghui Yang, Yingze Zhao, Jie Li, et al.
Medcomm
|
July 17, 2024
Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study
Xiaoyan Li, Shanghao Liu, Ying Guo, et al.
Signal Transduction and Targeted Therapy
|
February 11, 2021
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Lei Shi, Hai Huang, Xuechun Lu, et al.
Page
of 12